Skip to main content
. 2021 May 20;1(3):100026. doi: 10.1016/j.xjidi.2021.100026

Table 3.

Summary of Changes in Dimensions Based on the Diameters of Verruca Vulgaris Lesions in each Subgroup

FIT039 (n = 13) Placebo (n = 11) Group Comparison
Time Point n Mean (SD)
(mm2)
Change from Day 1 (95% CI) (%) n Mean (SD)
(mm2)
Change from Day 1 (95% CI) (%) Difference in Change from Day 1 (95% CI) (%) P-Value
Day 1 13 26.62 (15.47) N/A 11 34.34 (25.50) N/A N/A N/A
Day 8 13 24.16 (17.41) 88.11 (77.08–99.15) 11 34.34 (26.14) 98.20 (83.9–112.44) –10.08 (–26.78 to 6.61) 0.223
Day 15 13 23.13 (16.92) 86.16 (71.69–100.62) 11 35.09 (27.44) 100.33 (83.32–117.34) –14.17 (–35.0 to –6.71) 0.173
Day 29 13 21.01 (17.34) 75.98 (60.66–91.30) 11 35.85 (27.12) 101.35 (86.83–115.86) –25.37 (–45.52 to –5.21) 0.016
Day 43 13 21.28 (16.67) 78.24 (62.72–93.76) 11 36.54 (25.78) 107.31 (83.96–130.66) –29.07 (–54.96 to –3.46) 0.028
Day 57 13 23.87 (18.32) 97.62 (49.20–146.03) 11 36.60 (25.20) 107.35 (84.69–130.00) –9.73 (–63.59 to 44.12) 0.711

Abbreviations: CI, confidence interval; N/A, not applicable.

Change from day 1 (%) = ([value at each time point]/[value on day 1]) × 100.

Day 1 is defined as the day of application of the skin patch.